Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Texas biorepository aims to unlock Cancer's secrets

NCT ID NCT05371756

Knowledge-focused Sponsor: Baylor Research Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is building a large collection of blood, tissue, urine, and stool samples from 10,000 cancer patients across Texas. Researchers will match these samples with detailed medical records to study why some patients respond to cancer treatments while others do not. The goal is to create a resource that helps develop better diagnostics and therapies in the future.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this biorepository could help researchers develop better diagnostic tests and treatments for cancer by understanding why some patients respond to therapy and others do not.
What could go wrong
This is an observational study that collects samples for future research, not a treatment trial. It does not directly test any new therapy, so benefits for participants are indirect and may take years to materialize.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 10,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2020

Expected to finish

Sep 2050

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with suspected/confirmed cancers undergoing standard of care surgeries or with confirmed cancers receiving immunotherapeutic treatments.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participant is over 18 years of age at the time of signing the informed consent form. * Participant is able and willing to sign an informed consent form. * Participant is suspected by a provider of being at risk for developing cancer, OR * Participant has confirmed or clinically suspected malignancy by a provider. This includes but is not limited to: 1. Participants who may be candidates for or are scheduled to receive standard of care immunotherapy treatment for the first time for their current cancer diagnosis, regardless of any prior non-immunotherapy treatment. 2. Participants who are enrolled in a clinical trial to receive an investigational, novel immunotherapy drug for the first time for their current cancer diagnosis. 3. Participants who may be surgical candidates for their current cancer diagnosis, regardless of any prior treatment. Exclusion Criteria: * Participant is unable or unwilling to donate blood. * Concurrent medical or psychiatric condition or disease that may compromise the ability to give documented informed consent, is likely to interfere with study procedures or results, or that in the opinion of the investigator would constitute a hazard for participating in this study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    8 sites. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Baylor Scott & White All Saints Medical Center - Fort Worth

    RECRUITING

    Fort Worth, Texas, 76104, United States

    Contact Email: •••••@•••••

  • Baylor Scott & White Medical Center - College Station

    RECRUITING

    College Station, Texas, 77845, United States

    Contact Email: •••••@•••••

  • Baylor Scott & White Medical Center - Hillcrest

    RECRUITING

    Waco, Texas, 76712, United States

    Contact Email: •••••@•••••

  • Baylor Scott & White Medical Center - Plano

    RECRUITING

    Plano, Texas, 75093, United States

    Contact Email: •••••@•••••

  • Baylor Scott & White Medical Center - Round Rock

    RECRUITING

    Round Rock, Texas, 78665, United States

    Contact Email: •••••@•••••

  • Baylor Scott & White Medical Center - Temple

    RECRUITING

    Temple, Texas, 76508, United States

    Contact Email: •••••@•••••

  • Baylor Scott & White Medical Center - Waxahachie

    RECRUITING

    Waxahachie, Texas, 75165, United States

    Contact Email: •••••@•••••

  • Baylor University Medical Center - Dallas

    RECRUITING

    Dallas, Texas, 75246, United States

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.